AstraZeneca A/S

Trellis Bioscience Grants MedImmune License for Its Anti-RSV Antibodies.
Chemicals & Chemistry Business; 12/18/2009; 1087 words; ...the global biologics unit of AstraZeneca, to develop and commercialize...commercialization of Trellis's RSV antibodies worldwide. MedImmune...Trellis. "Given the company's deep expertise in the field of...Trellis. About CellSpot Trellis's patented CellSpot platform is...

Seattle Genetics to Present Brentuximab Vedotin and Dacetuzumab Data at the 51st American Society of Hematology Annual Meeting and Exposition.
Blood Weekly; 12/17/2009; 1422 words; ...Louisiana. A summary of the company's ASH presentations is below and full abstracts...and autoimmune disease. The company's lead product candidate, brentuximab vedotin...Daiichi Sankyo, MedImmune, a subsidiary of AstraZeneca, and Millennium: The Takeda Oncology...

Study results from AstraZeneca provide new insights into gastrointestinal reflux disease.
Biotech Week; 12/16/2009; 839 words; ...transporters. AR-H061719 [(R/S)-(3-amino-2-fluoropropyl...Lehmann and colleagues, AstraZeneca. The researchers concluded...by contacting A. Lehmann, AstraZeneca R&D, SE-43183 Molndal...Keywords: Country:Sweden, AstraZeneca, Baclofen, Biotechnology...

Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer.
Biotech Week; 12/16/2009; 563 words; ...will report directly to Nektar's President and Chief Executive...Therapeutics). "Lorianne's outstanding leadership and highly...in rapidly advancing Nektar's proprietary clinical pipeline...partnering of NKTR-118 with AstraZeneca," Robin said. "She has assembled...

US FDA Approves SEROQUEL XR for Add-On Treatment of Major Depressive Disorder.
Biotech Week; 12/16/2009; 1487 words; ...The FDA has required that AstraZeneca implement a Risk Evaluation...antidepressants." "Today's FDA approval of SEROQUEL XR...Schoenberg, VP Specialty Care, AstraZeneca. "This new indication for...disorders. In addition to today's approval for the adjunctive...